Dr. David A. Litvak MD
General Surgery
Patients Top Choice
Patients Top Choice
Patient Rating
Overview
Doctor's Details
Specialties
Specialty
General Surgery
Subspecialties
Hepatobiliary Surgery
Surgical Oncology (Other than Breast)
Doctor's Details
Patient Awards
Patients' top choice award
Doctor has top marks across all patient-rated categories
Patients recommend
Patients would recommend to friends and family.
Makes time for patients
Spends appropriate amount of time with patient and provides thorough examinations.
Listens attentively
Rated highly on their manner and listening skills.
Provides clear explanation
Provides clear information and answers questions in a way patients understand.
Patient Experience
Excellent
(5/5)
8 Reviews Total|0 Reviews Within Last 12 Months
Thoroughness of Examination
Previous patients' satisfaction in their perception of the thoroughness of the examination they received from this physician
Excellent
(5/5)
Ability to Answer Questions
Previous patients' assessment of this physician's ability to answer all of their questions
Excellent
(5/5)
Clarity of Instructions
Previous patients' satisfaction in the clarity of this physician's instructions for taking care of their health condition
Excellent
(5/5)
Provider's follow-up
Previous patients' satisfaction of the followup care they received from this physician and responsiveness to their concerns
Excellent
(5/5)
Amount of Time with Patient
Previous patients' satisfaction with the time this physician spent with them during appointments
Excellent
(5/5)
Provider's Attitude
Previous patients' assessment of this physician's friendliness and caring attitude
Excellent
(5/5)
Perceived Outcomes
Previous patients' satisfaction with the physician's treatment of a condition or outcome of a procedure
Excellent
(5/5)
Patient Loyalty
Previous patients' trust in this physician, likelihood to see this physician again, or willingness to recommend this physician to another patient
Excellent
(5/5)
General Feedback
Previous patients' general assessment of this physician
Excellent
(5/5)
See All Categories
Areas of Expertise for Dr. Litvak
This doctor provides the following types of care. The more often a doctor has treated a particular condition or has performed a particular surgery, the more expertise they may have in treating patients with similar needs. Based on three years (2020-2022) of Medicare Fee for Service data (which does not include Medicare Advantage), each scale below indicates the number of patients treated relative to other doctors who treat the same condition. Note that this doctor may treat patients who are not covered by Medicare and are therefore not included in this analysis. Click here to learn more about our methodology.
Surgical removal of colonSurgical removal of the colon, or colectomy, may be done to treat various conditions affecting the large intestine.
Check to See if Dr. David A. Litvak Accepts Your Insurance
Please contact your provider to confirm if they accept your insurance.
Accepted Insurance Plans
Don`t see your plan listed? Click here to find providers that accept your insurance.
General Surgeons Like Dr. Litvak Near Me
Location & Contact Information
Doctor Address
425 Haaland Dr, Suite 101, Thousand Oaks, CA, 91361
(805) 496-2949Affiliated Hospitals
City of Hope Comprehensive Cancer Center
Los Robles Hospital and Medical Center
Where does Dr. Litvak practice?
Doctor’s Office
Silicon Valley Medical Development Llc
Here are other providers that practice at the same doctor's office:
Hospital Affiliations
Los Robles Hospital and Medical CenterThousand Oaks, CA
#57 in California
Education & Experience
Medical School & Residency
University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
Medical School
Saint John’s Cancer Institute/Providence Saint John’s Health Center
Fellowship, Complex General Surgical Oncology, 2000-2002
University of California Davis Health
Residency, Surgery, 1993-2000
Certifications & Licensure
American Board of Surgery
Certified in Surgery
AZ State Medical License
Active through 2025
MI State Medical License
Active through 2006
CA State Medical License
Active through 2025
OH State Medical License
Active through 2024
Awards, Honors & Recognitions
ACS Fellow
Publications
Laparoscopic Splenectomy in Colorectal Cancer Patients with Chemotherapy-Associated Thrombocytopenia due to Hypersplenism
David A. Litvak, Salman Malad, Robert A. Wascher, Maurie Markman, Jiaxin Niu
Treatment of Elderly Breast Cancer Patients in a Community Hospital Setting
David A. Litvak, Rajeev Arora
Endogenous immune response to early- and intermediate-stage melanoma is correlated with outcomes and is independent of locoregional relapse and standard prognostic factors.
David A. Litvak, Rishab K. Gupta, Reynold Yee, Leslie A. Wanek, Wei Ye, Donald L. Morton
Surgery in the Aged Population: Surgical Oncology
Keith M. Monson, David A. Litvak, Richard J. Bold
Modulators of ceramide metabolism sensitize colorectal cancer cells to chemotherapy: a novel treatment strategy.
David A. Litvak, Anton J. Bilchik, Myles C. Cabot
The results of the Department of Defense's breast lymphatic mapping study.
David A. Litvak, Armando E. Giuliano
Systemic irinotecan and regional floxuridine after hepatic cytoreduction in 185 patients with unresectable colorectal cancer metastases.
David A. Litvak, Thomas F. Wood, George J. Tsioulias, Mathew H. Chung, Sant P. Chawla, Leland J. Foshag, Donald L. Morton, Kenneth P. Ramming, Anton J. Bilchik
Targeting Ceramide Metabolism—a Strategy for Overcoming Drug Resistance
Alex Senchenkov, David A. Litvak, Myles C. Cabot
Signaling mechanisms regulating bombesin-mediated AP-1 gene induction in the human gastric cancer SIIA.
Hong Jin Kim, B. Mark Evers, David A. Litvak, Mark R. Hellmich, Courtney M. Townsend
Induction of apoptosis in human gastric cancer by sodium butyrate.
David A. Litvak, Kevin O. Hwang, B. M. Evers, Courtney M. Townsend
Targeting Molecular Pathways with Camptothecin as Novel Therapy for Gastric Cancer
David A. Litvak, Harry T. Papaconstantinou, B. Mark Evers, Courtney M. Townsend
Intestinal adaptation and enterocyte apoptosis following small bowel resection is p53 independent.
Cathy E. Shin, Richard A. Falcone, Christopher J. Kemp, Christopher R. Erwin, David A. Litvak, B. Mark Evers, Brad W. Warner
Inhibition of gastric cancer by camptothecin involves apoptosis and multiple cellular pathways
David A. Litvak, Harry T. Papaconstantinou, Kevin O. Hwang, Mimi Kim, B. Mark Evers, Courtney M. Townsend
Enterotrophic effects of glucagon-like peptide 2 are enhanced by neurotensin
David A. Litvak, B. Mark Evers, Mark R. Hellmich, Courtney M. Townsend
Characterization of two novel proabsorptive peptide YY analogs, BIM- 43073D and BIM-43004C
David A. Litvak, Iseki H, Evers Bm, Greeley Gh, Mark R. Hellmich, Iwase K, Ambikaipakan Balasubramaniam, Courtney M. Townsend
JMV1155: a novel inhibitor of glycine-extended progastrin-mediated growth of a human colon cancer in vivo.
David A. Litvak, Mark R. Hellmich, Iwase K, B. M. Evers, Martinez J, Amblard M, Courtney M. Townsend
A novel cytotoxic agent for human carcinoid tumors
David A. Litvak, Harry T. Papaconstantinou, Tien C. Ko, Courtney M. Townsend
Butyrate-induced differentiation of Caco-2 cells is associated with apoptosis and early induction of p21Waf1/Cip1 and p27Kip1
David A. Litvak, B. Mark Evers, Kevin O. Hwang, Mark R. Hellmich, Tien C. Ko, Courtney M. Townsend
Glucagon-like peptide 2 is a potent growth factor for small intestine and colon☆☆☆
David A. Litvak, Mark R. Hellmich, B. Mark Evers, Nitesh A. Banker, Courtney M. Townsend
Frequently Asked Questions About Dr. Litvak
Let us know if this information is out of date or incorrect.
Report a correction to this profileAre you Dr. David A. Litvak?
Claim or edit this profile at
Doctor's Details
